These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38181288)

  • 1. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis.
    Han JM; Guo L; Chen XH; Xie Q; Song XY; Ma YL
    Medicine (Baltimore); 2024 Jan; 103(1):e36784. PubMed ID: 38181288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis.
    Ge X; Zheng L; Zhuang R; Yu P; Xu Z; Liu G; Xi X; Zhou X; Fan H
    Adv Nutr; 2020 Jan; 11(1):66-76. PubMed ID: 31269204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-associated trimethylamine N-oxide and increased cardiometabolic risk in adults: a systematic review and dose-response meta-analysis.
    Abbasalizad Farhangi M; Vajdi M
    Nutr Rev; 2021 Aug; 79(9):1022-1042. PubMed ID: 33270896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation.
    Yang WT; Yang R; Zhao Q; Li XD; Wang YT
    Ann Palliat Med; 2021 Nov; 10(11):11512-11523. PubMed ID: 34872276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis.
    Dehghan P; Farhangi MA; Nikniaz L; Nikniaz Z; Asghari-Jafarabadi M
    Obes Rev; 2020 May; 21(5):e12993. PubMed ID: 32017391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis.
    Guasti L; Galliazzo S; Molaro M; Visconti E; Pennella B; Gaudio GV; Lupi A; Grandi AM; Squizzato A
    Intern Emerg Med; 2021 Jan; 16(1):201-207. PubMed ID: 32779113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
    Zhuang R; Ge X; Han L; Yu P; Gong X; Meng Q; Zhang Y; Fan H; Zheng L; Liu Z; Zhou X
    Obes Rev; 2019 Jun; 20(6):883-894. PubMed ID: 30868721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
    Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.
    Qi J; You T; Li J; Pan T; Xiang L; Han Y; Zhu L
    J Cell Mol Med; 2018 Jan; 22(1):185-194. PubMed ID: 28782886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.
    Li D; Lu Y; Yuan S; Cai X; He Y; Chen J; Wu Q; He D; Fang A; Bo Y; Song P; Bogaert D; Tsilidis K; Larsson SC; Yu H; Zhu H; Theodoratou E; Zhu Y; Li X
    Am J Clin Nutr; 2022 Jul; 116(1):230-243. PubMed ID: 35348578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
    Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
    Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the Impact of Bariatric Surgery on Circulating TMAO Levels as a Predictor of Cardiovascular Disease Risk.
    Jamialahmadi T; Simental-Mendia LE; Zengin G; Almahmeed W; Kesharwani P; Sahebkar A
    Curr Med Chem; 2024; 31(24):3791-3797. PubMed ID: 37226793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose-response meta-analysis.
    Farhangi MA; Vajdi M; Asghari-Jafarabadi M
    Nutr J; 2020 Jul; 19(1):76. PubMed ID: 32731904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies.
    Zhang H; Yao G
    Eur J Clin Nutr; 2023 Jul; 77(7):731-740. PubMed ID: 35468932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease.
    Thomas MS; Fernandez ML
    Curr Atheroscler Rep; 2021 Feb; 23(4):12. PubMed ID: 33594574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Tatsanavivat P; Sritara P; Phrommintikul A
    Sci Rep; 2021 Jul; 11(1):14963. PubMed ID: 34294762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population.
    Zheng L; Zheng J; Xie Y; Li Z; Guo X; Sun G; Sun Z; Xing F; Sun Y
    Atherosclerosis; 2019 Jan; 280():126-131. PubMed ID: 30508691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel findings of the association between gut microbiota-derived metabolite trimethylamine
    Farhangi MA; Vajdi M
    Crit Rev Food Sci Nutr; 2020; 60(16):2801-2823. PubMed ID: 32462890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease.
    Bean LD; Wing JJ; Harris RE; Smart SM; Raman SV; Milks MW
    BMC Cardiovasc Disord; 2022 May; 22(1):209. PubMed ID: 35538408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.